In a mouse model of melanoma, commensal Bifidobacterium contributed to the differences in responses to ICIs, and the antitumor efficacy of PD-L1 was enhanced through fecal microbiota transplantation (FMT) [77]. This evidence concerns the gene CD274 and melanoma.